AI accelerates the hunt for new antibiotics against resistance

AI is speeding antibiotic discovery by predicting targets and mechanisms, narrowing experimental pipelines, and enabling design of new antimicrobials—from small-molecule inhibitors like halicin to antimicrobial peptides developed via de-extinction (APEXGO). The approach relies on diverse, high-quality training data and practical synthesis constraints, as researchers race to outpace antibiotic resistance.